Clinical status of agents being developed for leishmaniasis
@article{Berman2005ClinicalSO, title={Clinical status of agents being developed for leishmaniasis}, author={J. Berman}, journal={Expert Opinion on Investigational Drugs}, year={2005}, volume={14}, pages={1337 - 1346} }
Leishmaniasis, which exists in both visceral and cutaneous forms, is currently treated with intramuscular antimony or intravenous amphotericin B. The primary unmet need is for oral therapy. Of the several drugs in clinical development, miltefosine is unique in being an oral agent with efficacy against both forms of the disease. Sitamaquine is an oral agent with substantial but not sufficient efficacy against visceral disease. Oral fluconazole has been shown to be more effective than placebo in… Expand
Topics from this paper
54 Citations
Drug delivery systems for the topical treatment of cutaneous leishmaniasis
- Medicine
- Expert opinion on drug delivery
- 2012
- 37
Drug-containing hydrophobic dressings as a topical experimental therapy for cutaneous leishmaniasis
- Medicine
- Journal of Parasitic Diseases
- 2019
- Highly Influenced
Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
- Medicine
- The Journal of antimicrobial chemotherapy
- 2009
- 28
- Highly Influenced
- PDF
Reductions in Skin and Systemic Parasite Burdens as a Combined Effect of Topical Paromomycin and Oral Miltefosine Treatment of Mice Experimentally Infected with Leishmania (Leishmania) amazonensis
- Medicine, Biology
- Antimicrobial Agents and Chemotherapy
- 2010
- 29
- PDF
References
SHOWING 1-10 OF 67 REFERENCES
Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis.
- Medicine
- The New England journal of medicine
- 1999
- 435
Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator.
- Medicine
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
- 2001
- 194
- PDF
Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis.
- Medicine
- The American journal of medicine
- 1990
- 146
Oral miltefosine for Indian visceral leishmaniasis.
- Medicine
- The New England journal of medicine
- 2002
- 660
- PDF
Cutaneous Leishmaniasis Caused by Leishmania tropica: Treatment with Oral Fluconazole
- Medicine
- Dermatology
- 2005
- 13
Itraconazole and leishmaniasis: a randomised double-blind trial in cutaneous disease.
- Biology, Medicine
- International journal for parasitology
- 1996
- 70
Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major.
- Medicine
- The New England journal of medicine
- 2002
- 283
Allopurinol in the treatment of American cutaneous leishmaniasis.
- Medicine
- The New England journal of medicine
- 1992
- 134
Cutaneous leishmaniasis in a Kosovan child treated with oral fluconazole
- Medicine
- Clinical and experimental dermatology
- 2004
- 17